MONTREAL, CANADA--(Marketwire - February 20, 2008) - ART Advanced Research Technologies Inc. (“ART”) (TSX: ARA), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, is pleased to announce the first sale of its SoftScan® optical breast imaging system to the Sunnybrook Health Sciences Centre (‘Sunnybrook”) in Toronto, Canada. Sunnybrook is the first health centre to purchase a SoftScan imaging system since ART received regulatory approval from Health Canada for the commercialization of its optical breast imaging device.
